Vol.63 No.3 May 2015

Current status of anti-viral drug development of anti-herpetic drug ASP2151 and anti-influenza drug T-705

Kimiyasu Shiraki

Jpn. J. Chemother. 63 (3): 330-338, 2015

The issues of resistant organisms in the treatment of surgical site infections in colorectal surgery

Hiroki Ohge, Toshinori Hara, Norifumi Shigemoto, Yumiko Koba, Maki Furushimo, Rie Nagaoka, Makoto Onodera, Shizuo Kayama, Motoyuki Sugai and Taijiro Sueda

Jpn. J. Chemother. 63 (3): 339-342, 2015

The drug susceptibility of major causative urinary tract infection bacteria, and molecular characterisation of the quinolone resistance-determining regions (QRDR) including gyrA and parC

Takeshi Ieda, Kyoko Kuwahara, Yuh Morimoto, Shin-ichi Hisasue, Teruyo Ito, Shigeo Horie and Keiichi Hiramatsu

Jpn. J. Chemother. 63 (3): 343-349, 2015

Evaluation of interventions for bloodstream infections by an antimicrobial stewardship team in a Japanese university hospital

Masayuki Maeda, Takahiro Takuma, Masayuki Yoshikawa, Yuika Naito, Ayumi Tsuchiya, Yuji Oto, Atsuko Minemura, Kazuhisa Ugajin, Hisashi Shoji, Keiko Ishino and Yoshihito Niki

Jpn. J. Chemother. 63 (3): 350-356, 2015

Therapeutic drug monitoring questionnaire survey of glycopeptide agents in Japan

Takashi Ueda, Yoshio Takesue, Kazuhiko Nakajima, Kaoru Ichiki, Akihiro Doita, Yasunao Wada, Toshie Tsuchida, Yoshiko Takahashi, Mika Ishihara and Takeshi Kimura

Jpn. J. Chemother. 63 (3): 357-364, 2015